Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat ...

The latest iteration of GLP-1 misinformation revolves around bones.

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat ...

Me turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total ...

While the study highlights potential psychiatric benefits, the medications are linked to known risks including ...

A study, published in Nature, investigated drugs such as semaglutide and tirzepatide, which have gained global attention for ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

The study finds specific genetic variants that predict how much weight a person will lose on taking weight loss drugs, & the ...

Tirzepatide produced notable weight loss in real-world settings, but patients with prior weight loss experienced smaller additional reductions than those without.

Why do Ozempic and Zepbound work differently for everyone? A new study identifies genetic variants linked to GLP-1 weight loss and side effects.

Learn why rapid weight loss may trigger hair loss with Ozempic and discover ways to minimize shedding and regrow your hair.

Some recent studies have raised questions about a possible association between GLP-1 drugs and ischaemic optic neuropathy, ...